윤경호 연구실
원광대학교 의학과
윤경호 교수
윤경호 교수 연구실
홈
윤경호 연구실
원광대학교 의학과 윤경호 교수
윤경호 연구실은 순환기내과를 중심으로 관상동맥질환과 급성관상동맥증후군 환자의 중재시술 최적화, 혈관내 영상 기반 정밀치료, 항혈소판·항응고 약물전략, 스타틴 및 지질강하 치료를 포함한 심혈관 예방 연구를 수행하며, 대규모 다기관 임상시험과 실제 임상 문제를 연결하는 근거 중심의 중재심장학 연구에 강점을 지닌다.
대표 연구 분야
연구 영역 전체보기
관상동맥중재시술과 혈관내 영상 기반 정밀 치료
관상동맥중재시술과 혈관내 영상 기반 정밀 치료
항혈소판·항응고 약물치료 최적화와 심혈관 임상시험
이상지질혈증 관리와 죽상경화성 심혈관질환 예방
연구 성과 추이
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
5개년 연도별 논문 게재 수
90총합
5개년 연도별 피인용 수
2,255총합
주요 논문
3
논문 전체보기
1
article
|
인용수 11
·
2025Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents
Seung‐Jun Lee, Hee Tae Yu, Yong-Joon Lee, Sang‐Hyup Lee, Jung Ho Heo, Sung Gyun Ahn, Sanghoon Shin, Joon‐Hyung Doh, Ae‐Young Her, Byung Ryul Cho, Gwang-Sil Kim, Taek‐Geun Kwon, Sang Wook Lim, Jaemin Shim, Ji-Yong Jang, Kyounghoon Lee, Yun‐Hyeong Cho, Cheol Ung Choi, Sang Rok Lee, Hyung‐Bok Park, Han Cheol Lee, Seunghwan Kim, Kyeong Ho Yun, Jong Hwa Ahn, Byoung Kwon Lee, Deok‐Kyu Cho, Song‐Yi Kim, Ung Kim, Tae Soo Kang, Seong Huan Choi, Won–Ho Kim, Jin Bae Lee, Moo‐Yong Rhee, Jin‐Bae Kim, Sang‐Ho Jo, Dae Woo Hyun, Daehoon Kim, Tae-Hoon Kim, Sung‐Jin Hong, Jae‐Sun Uhm, Dong‐Ho Shin, Chul‐Min Ahn, Byeong‐Keuk Kim, Boyoung Joung, Young‐Guk Ko, Donghoon Choi, Myeong‐Ki Hong, Yangsoo Jang, Hui‐Nam Pak, Jung‐Sun Kim
New England Journal of Medicine
Among patients with atrial fibrillation who had undergone implantation of a drug-eluting stent at least 1 year earlier, NOAC monotherapy was noninferior to combination therapy for net adverse clinical events. (Funded by Cardiovascular Research Center and Samjin Pharmaceutical; ADAPT AF-DES ClinicalTrials.gov number, NCT04250116.).
https://doi.org/10.1056/nejmoa2512091
Atrial fibrillation
Adverse effect
Stent
Coronary artery disease
Clinical trial
2
article
|
인용수 52
·
2025Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial
Ki Hong Choi, Yong Hwan Park, Jong‐Young Lee, Jin‐Ok Jeong, Chan Joon Kim, Kyeong Ho Yun, Han Cheol Lee, Kiyuk Chang, Mahn‐Won Park, Jang‐Whan Bae, Joon‐Hyung Doh, Byung Ryul Cho, Hee-Yeol Kim, Weon Kim, Ung Kim, Seung‐Woon Rha, Young Joon Hong, Hyun‐Jong Lee, Sung Gyun Ahn, Doo‐Il Kim, Jang Hyun Cho, Sung‐Ho Her, Doo Soo Jeon, Seung Hwan Han, Jin Bae Lee, Cheol Whan Lee, Danbee Kang, Joo Myung Lee, Taek Kyu Park, Jeong Hoon Yang, Soo‐Youn Lee, Seung-Hyuk Choi, Hyeon‐Cheol Gwon, Young Bin Song, Joo-Yong Hahn
The Lancet
https://doi.org/10.1016/s0140-6736(25)00449-0
Medicine
Clopidogrel
Aspirin
Percutaneous coronary intervention
Cardiovascular event
Internal medicine
Randomized controlled trial
Open label
Conventional PCI
Cardiology
3
article
|
green
·
인용수 289·
2022Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
Byeong‐Keuk Kim, Sung‐Jin Hong, Yong‐Joon Lee, Soon Jun Hong, Kyeong Ho Yun, Bum‐Kee Hong, Jung Ho Heo, Seung‐Woon Rha, Yun‐Hyeong Cho, Seung‐Jun Lee, Chul‐Min Ahn, Jung‐Sun Kim, Young‐Guk Ko, Donghoon Choi, Yangsoo Jang, Myeong‐Ki Hong
IF 168.9 (2022)
The Lancet
https://doi.org/10.1016/s0140-6736(22)00916-3
Medicine
Ezetimibe
Statin
Rosuvastatin
Internal medicine
Clinical endpoint
Combination therapy
Adverse effect
Population
Randomized controlled trial